NCT02657616View on ClinicalTrials.gov

Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA

CompletedOBSERVATIONAL

Enrollment

204,464

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2015

Conditions

Atrial FibrillationStroke Prophylaxis

Interventions

DRUG

vitamin-k-antagonists

DRUG

Novel oral anticoagulants

All Listed Sponsors

lead

Institut für Pharmakoökonomie und Arzneimittellogistik e.V.

OTHER

NCT02657616 - Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA | Biotech Hunter | Biotech Hunter